By
Kyle Brasseur2023-12-15T19:37:00
The Securities and Exchange Commission (SEC) denied a petition filed on behalf of cryptocurrency exchange platform Coinbase that called for the creation of a new regulatory framework for crypto asset securities.
On Friday, the SEC notified Coinbase Chief Legal Officer Paul Grewal of its decision regarding his call for cryptocurrency rulemaking. The agency’s response said it disagreed with Grewal’s belief the existing regulatory framework around crypto assets securities is unworkable.
“The commission is also engaged in many undertakings that relate to regulatory priorities extending well beyond crypto asset securities,” the agency’s letter to Grewal stated. “The requested regulatory action would significantly constrain the commission’s choices regarding competing priorities, and the commission declines to undertake it at this time.”
2024-07-26T15:51:00Z By Aaron Nicodemus
The U.K. Financial Conduct Authority issued a fine of $4.5 million (3.5 million pounds) against a U.K.-based subsidiary of crypto platform Coinbase for providing services to high-risk customers in violation of FCA rules.
2024-04-09T20:33:00Z By Adrianne Appel
Hester Peirce of the Securities and Exchange Commission said the agency should form an advisory committee comprised of chief compliance officers as part of a wide-ranging critique of the agency’s efforts to engage with the public.
2024-01-24T22:54:00Z By Jeff Dale
The Financial Industry Regulatory Authority announced it uncovered potential violations of its disclosure rules in 70 percent of crypto asset communications reviewed during a targeted exam.
2025-12-10T15:30:00Z By Neil Hodge
For the past decade, Europe has led in creating strong but flexible rules for data use and safe AI development. The EU’s new plans to simplify key data privacy and AI governance measures have received a mixed response.
2025-12-05T19:25:00Z By Oscar Gonzalez
The U.S. Securities and Exchange Commission’s (SEC) Division of Examinations released its 2026 examination priorities, which give companies a roadmap of areas of heightened risk and regulatory focus for next year.
2025-12-04T22:15:00Z By Ruth Prickett
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
Site powered by Webvision Cloud